Assessing post-stroke cognition in pre-clinical models: Lessons and recommendations from a multi-center study

Area of Science:

• Neuroscience
• Stroke Research
• Cognitive Impairment

Background:

• Cognitive decline is a major long-term consequence of stroke.
• Currently, no effective treatments exist for post-stroke cognitive impairment.
• Robust detection of cognitive performance is crucial for developing new therapies.

Purpose of the Study:

• To establish a reliable method for detecting cognitive performance deficits after stroke in a multi-site research setting.
• To evaluate the effectiveness of different stroke induction methods on cognitive function.
• To identify challenges and provide recommendations for future pre-clinical stroke cognition studies.

Main Methods:

• Ischemic stroke was induced in mice using permanent distal middle cerebral artery occlusion (dMCAO) or transient MCAO.
• Cognitive function was assessed using Novel Object Recognition (NOR) and Barnes Maze (BM) tests at various time points post-stroke.
• Histology, immunostaining, and plasma neurofilament light chain levels were used to evaluate brain damage.

Main Results:

• The Novel Object Recognition test did not detect significant cognitive deficits.
• The Barnes Maze test revealed significantly worse performance in mice that underwent dMCAO.
• Histological analysis confirmed varying degrees of tissue damage and neuronal loss based on stroke model.

Conclusions:

• The Barnes Maze test shows promise for detecting post-stroke cognitive deficits in pre-clinical models, but requires multi-site validation.
• Detecting cognitive impairment after stroke presents significant challenges, particularly in multi-site studies.
• Standardized methodologies and careful study design are essential for future pre-clinical stroke cognition research.